Skip to main content
SpringerLink
Log in

The relevance of POCT in healthcare

  • Chapter
Point-of-Care Testing

  • 1724 Accesses

Abstract

Near-patient laboratory diagnostics has a long history and is now an indispensable part of clinical medicine. On the one hand, devices incorporating POCT fulfill the medical rationale of shortening the time from blood draw to treatment decision. On the other, POCT analyzers can also be provided for organizational reasons, rendering feasible options like the ability to improve clinical processes or enhance patient satisfaction. Considering the numerous tests that are freely available, strict quality assurance is required and mandatory for most methods.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bietenbeck A, Junker R, Luppa PB (2015) Central laboratory service and Point-of-Care Testing in Germany – From conflicting notions to complementary understandings. Point Care J Near-Patient Test Technol 14: 1–11

    Google Scholar 

  2. Bundesärztekammer (German Medical Association) (2014) Guideline of the German Medical Association for the Quality Assurance of Clinical Laboratory Testing (Rili-BÄK 2014). Dtsch Ärztebl 111:A1583–1618

    Google Scholar 

  3. Doyle NM, Levison JE, Gardner MO (2005) Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis. Am J Obstet Gynecol 193: 1280–1285

    Article  PubMed  Google Scholar 

  4. Drenck N (2001) Point of care testing in critical care medicine: The clinician’s view. Clin Chim Acta 307: 3–7

    Article  CAS  Google Scholar 

  5. Gruszecki AC, Hortin G, Lam J et al. (2003) Utilization, reliability, and clinical impact of point-of-care testing during critical care transport: Six years of experience. Clin Chem 49: 1017–1019

    Article  CAS  PubMed  Google Scholar 

  6. Hänecke P, Haeckel R, Koschinsky T, Luppa P, Schlebusch H, Wahl HG (2004) Qualitätssicherung in der patientennahen Sofortdiagnostik (Point-of-Care Testing) im Krankenhaus: Muster für eine hausinterne Richtlinie. J Lab Med 28: 256–263

    Google Scholar 

  7. Jani IV, Peter TF (2013) How Point-of-Care Testing could drive innovation in global health. N Engl J Med 368: 2319–2324

    Article  CAS  PubMed  Google Scholar 

  8. Kost GJ, Tran NK. Effects of point-of-care testing on time, process, decision making, treatment and outcome. In: Kost GJ (ed) (2002) Principles and practice of point-of-care testing. Lippincott Williams & Wilkins, Philadelphia, pp 605–611

    Google Scholar 

  9. Kost GJ, Tran NK (2002) The economics of point-of-care testing. In: Kost GJ (ed) Principles and practice of point-of-care testing. Lippincott Williams & Wilkins, Philadelphia, pp 613–622

    Google Scholar 

  10. Kost GJ (2002) Controlling economics, preventing errors, and optimizing outcome in point-of-care testing. In: Kost GJ (ed) Principles and practice of point-of-care testing. Lippincott Williams & Wilkins, Philadelphia, pp 577–600

    Chapter  Google Scholar 

  11. Kost GJ (2002) Goals, guidelines, and principles for point-of-care testing. In: Kost GJ (ed) Principles and practice of point-of-care testing. Lippincott Williams & Wilkins, Philadelphia, pp 3–12

    Google Scholar 

  12. Luppa P, Junker R (2010) Verantwortung für die Durchführung der Qualitätssicherung einer dezentral organisierten Laboratoriumsdiagnostik im Krankenhaus. Klin. Chemie Mitteilungen 41:205–8

    Google Scholar 

  13. Luppa PB, Müller C, Schlichtiger A, Schlebusch H (2011) Point-of-care testing (POCT): Current techniques and future perspectives. Tr Anal Chem 30: 887–898

    Article  CAS  Google Scholar 

  14. Mahtabjafari M, Masih M, Emerson AE (2001) The value of pharmacist involvement in a point-of-care service, walk-in lipid screening program. Pharmacotherapy 21: 1403–1406

    Article  Google Scholar 

  15. National Academy of Clinical Biochemistry (NACB) (2007) Practice guidelines: Evidence-based practice for point-of-care testing. Point of care 6: 213–217

    Google Scholar 

  16. Peterson GM, Fitzmaurice KD, Naunton M, Vial JH, Stewart K, Krum H (2004) Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy. J Clin Pharm Ther 29: 23–30

    Article  CAS  PubMed  Google Scholar 

  17. Price CP, St. John A (2014) Innovation in healthcare. The challenge for laboratory medicine. Clin Chim Acta 427: 71–78

    Article  CAS  Google Scholar 

  18. Robert LS, Edward HL (2007) Point-of-care testing: Guidelines and challenges. NC Med J 68: 132–135

    Google Scholar 

  19. Schlüter B, Junker R (2003) Labordiagnostik – Schneller ist nicht immer besser. Dtsch Ärztebl 100: A87–A89

    Google Scholar 

  20. Scott MG (2000) Faster is better – It’s rarely that simple! Clin Chem 46: 441–442

    Google Scholar 

  21. Till LT, Voris JC, Horst JB (2003) Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting. J Manag Care Pharm 9: 269–273

    Article  PubMed  Google Scholar 

  22. van Heyningen C, Watson ID, Morrice AE (1999) Point-of-care testing outcomes in an emergency department. Clin Chem 45: 437–438

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinikum Schleswig-Holstein, Institut für Klinische Chemie, Arnold-Heller-Str. 3, 24105, Kiel, Germany

    Prof. Dr. Ralf Junker

  2. Universitätsmedizin Greifswald, Institut für Klinische Chemie und Laboratoriumsmedizin, Ferdinand-Sauerbruchstr., 17475, Greifswald, Germany

    Priv.-Doz. Dr. Astrid Petersmann

  3. Klinikum rechts der TU München, Institut für Klinische Chemie und Pathobiochemie, Ismaninger Str. 22, 81675, München, Germany

    Prof. Dr. Peter B. Luppa

Authors
  1. Prof. Dr. Ralf Junker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Priv.-Doz. Dr. Astrid Petersmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prof. Dr. Peter B. Luppa
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinikum rechts der Isar, München, Germany

    Peter B. Luppa

  2. Universitätsklinikum Schleswig-Holstein, Kiel, Germany

    Ralf Junker

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer-Verlag GmbH Germany, part of Springer Nature

About this chapter

Cite this chapter

Junker, R., Petersmann, A., Luppa, P.B. (2018). The relevance of POCT in healthcare. In: Luppa, P.B., Junker, R. (eds) Point-of-Care Testing. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54497-6_2

Download citation

Publish with us

Policies and ethics

Search

Navigation